Trastuzumab

Women with HER2-positive breast cancer and who is taking the drug trastuzumab in addition to chemotherapy is said to have a greater risk of heart problems during treatment. A study has shown that the incidence of such tribulations does not augment in the short term and that many women recover heart wellbeing after an initial decline. However, the long-term causes of trastuzumab on the heart is still remained to be resolved. Approximately 20 percent of breast cancers create extra of overexpress, a protein described as HER2. These tumors tend to produce faster and are more likely to recur tumors. Nonetheless, these examinations are found in women who took trastuzumab and had a boost in congestive heart failure or other heart problems.